VistaGen Therapeutics Inc

NASDAQ:VTGN  
2.98
+0.06 (+2.06%)
4:25:33 PM EDT: $2.97 -0.01 (-0.34%)
Earnings Announcements

Vistagen Therapeutics Reports Fiscal Year 2022 First Quarter Financial Results And Provides Corporate Update

Published: 08/12/2021 22:05 GMT
VistaGen Therapeutics Inc (VTGN) - Vistagen Therapeutics Reports Fiscal Year 2022 First Quarter Financial Results and Provides Corporate Update.
Vistagen Therapeutics Inc- Qtrly Loss per Share $0.04.
Revenue is expected to be $0.34 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0.34 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.